Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982488priorityCriticalpatent/ECSP982488A/en
Publication of ECSP982488ApublicationCriticalpatent/ECSP982488A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
El invento se refiere a un método mejorado de procesamiento de una solución aucosa de proteína C activada, que comprende la conducción de dicho proceso a una potencia iónica de más de 150mM y a un pH de aproximadamente 5,5 hasta menos de 6.3The invention relates to an improved method of processing an aucosa activated protein C solution, comprising driving said process to an ionic strength of more than 150mM and a pH of approximately 5.5 to less than 6.3
ECSP9824881998-04-271998-04-27
IMPROVED METHODS FOR PROCESSING OF ACTIVATED C PROTEIN
ECSP982488A
(en)
APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR, MATRIC METALLOPROTEINASE INHIBITOR, ANTI-TUMOR MEDICINE, AND OPTIONAL IRRADIATION AS A COMBINED METHOD OF TREATING THE NEO.